The ATN Innovation Summit is Less Than a Month Away
Join the industry’s top fitness and wellness leaders in New York City.
New data from Noom suggests that people who put more effort into eating healthy and working out see the best results from weight-loss drugs.
Digital healthcare platform Noom is launching oral weight loss medication, beginning with FDA-approved Metformin.
As GLP-1 drugs surge, here's how telehealth companies and brick-and-mortar fitness giants are responding to the Ozempic era.
Zumba instructors can gain an edge by becoming Noom Mindset Coaches as the dance-fitness brand continues to expand its reach.
A new market has emerged which focuses on maintaining the lean muscle mass of consumers taking weight-loss drugs like Ozempic.
Noom co-founder Saeju Jeong will continue as the wellness company's executive chairman of the board after serving as CEO for 16 years.
Sign Up to Our Newsletter
